Johnson & Johnson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About JNJ

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. 

CEO
Joaquin Duato
CEOJoaquin Duato
Employees
140,800
Employees140,800
Headquarters
New Brunswick, New Jersey
HeadquartersNew Brunswick, New Jersey
Founded
1887
Founded1887
Employees
140,800
Employees140,800

JNJ Key Statistics

Market cap
562.56B
Market cap562.56B
Price-Earnings ratio
27.12
Price-Earnings ratio27.12
Dividend yield
2.22%
Dividend yield2.22%
Average volume
7.30M
Average volume7.30M
High today
$235.54
High today$235.54
Low today
$232.92
Low today$232.92
Open price
$234.64
Open price$234.64
Volume
1.04M
Volume1.04M
52 Week high
$251.71
52 Week high$251.71
52 Week low
$146.12
52 Week low$146.12

Stock Snapshot

With a market cap of 562.56B, Johnson & Johnson(JNJ) trades at $233.56. The stock has a price-to-earnings ratio of 27.12 and currently yields dividends of 2.2%.

On 2026-04-17, Johnson & Johnson(JNJ) stock traded between a low of $232.92 and a high of $235.54. Shares are currently priced at $233.56, which is +0.3% above the low and -0.8% below the high.

Johnson & Johnson(JNJ) shares are trading with a volume of 1.04M, against a daily average of 7.3M.

In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $251.71 and a 52-week low of $146.12.

In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $251.71 and a 52-week low of $146.12.

JNJ News

Seeking Alpha 46m
Dividend Roundup: Johnson & Johnson, Costco, Caterpillar, CVS Health, and more

This week's dividend activity included increased payouts from Johnson & Johnson (JNJ) and Costco (COST) as well as declarations from companies such Texas Instru...

Dividend Roundup: Johnson & Johnson, Costco, Caterpillar, CVS Health, and more
TipRanks 18h
Johnson & Johnson’s Stelara gets FDA approval for added indication

The FDA approved an sBLA submitted by Johnson & Johnson’s Janssen Biotech for the addition of an indication for the treatment of pediatric patients 2 years and...

Nasdaq 18h
This "Boring" Dividend King Is Quietly Turning Into a Growth Machine

Key Points J&J’s stock has rallied over the past 12 months. It’s a solid safe-haven stock, but it could have more upside than its peers. 10 stocks we like be...

This "Boring" Dividend King Is Quietly Turning Into a Growth Machine

Analyst ratings

59%

of 29 ratings
Buy
58.6%
Hold
34.5%
Sell
6.9%

More JNJ News

Simply Wall St 18h
What Johnson & Johnson's Q1 Revenue Gain And 64th Straight Dividend Hike Mean For Shareholders

In April 2026, Johnson & Johnson reported first-quarter sales of US$24,062 million versus US$21,893 million a year earlier, alongside a quarterly dividend incre...

What Johnson & Johnson's Q1 Revenue Gain And 64th Straight Dividend Hike Mean For Shareholders
Benzinga 23h
Eli Lilly Partner MeiraGTx Regains Rights For Genetic Eye Disease Drug From Johnson & Johnson

XLRP is a severe, progressive genetic eye disease causing early-onset night blindness and peripheral vision loss, leading to legal blindness by age 40–45. Meira...

Eli Lilly Partner MeiraGTx Regains Rights For Genetic Eye Disease Drug From Johnson & Johnson
Benzinga 2d
These Analysts Boost Their Forecasts On Johnson & Johnson Following Strong Q1 Results

Johnson & Johnson (NYSE:JNJ) on Tuesday posted upbeat earnings for the first quarter. The company reported first-quarter 2025 adjusted earnings of $2.70 per sh...

These Analysts Boost Their Forecasts On Johnson & Johnson Following Strong Q1 Results
TipRanks 3d
Johnson & Johnson Bets Big on Next-Gen Growth

Johnson & Johnson ((JNJ)) has held its Q1 earnings call. Read on for the main highlights of the call. Claim 30% Off TipRanks Unlock hedge fund-level data and po...

CNBC 3d
J&J is off to a strong start in 2026 — here's how our newest stock can build on it

Johnson & Johnson on Tuesday validated our decision to make it our newest Club stock, delivering a beat-and-raise quarter led by its most important growth medic...

J&J is off to a strong start in 2026 — here's how our newest stock can build on it
24/7 Wall St. 3d
Johnson and Johnson Raises Dividend for 64th Consecutive Year

Johnson and Johnson Raises Dividend for 64th Consecutive Year By Joel South Published Apr 14, 12:55PM EDT Quick Read Johnson & Johnson (JNJ) raised its quarte...

Johnson and Johnson Raises Dividend for 64th Consecutive Year
Benzinga 3d
Johnson & Johnson Q1 2026 Earnings Call Transcript

Good morning and welcome to Johnson & Johnson’s first quarter 2026 earnings conference call. All participants will be in the listen only mode until the question...

Johnson & Johnson Q1 2026 Earnings Call Transcript

People also own

Based on the portfolios of people who own JNJ. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.